Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
The present study has evaluated the protection conferred by a single subcutaneous dose of a modified vaccinia virus Ankara (MVA) vectored vaccine encoding the Rift Valley Fever virus (RVFV) glycoproteins Gn and Gc in lambs. Three groups of six to seven lambs were immunized as follows: one group rece...
Main Authors: | Busquets, N, Lorenzo, G, López-Gil, E, Rivas, R, Solanes, D, Galindo-Cardiel, I, Abad, F, Rodríguez, F, Bensaid, A, Warimwe, G, Gilbert, S, Domingo, M, Brun, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Elsevier
2014
|
Títulos similares
-
Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
por: Busquets, N, et al.
Publicado: (2014) -
Evaluation of the protective potential of a recombinant modified vaccinia virus Ankara (MVA) encoding rift valley fever virus (RVFV) glycoproteins in lambs
por: Busquets, N, et al.
Publicado: (2011) -
Rift Valley fever: biology and epidemiology
por: Wright, D, et al.
Publicado: (2019) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
por: Warimwe, G, et al.
Publicado: (2013) -
MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses
por: Elena López-Gil, et al.
Publicado: (2020-02-01)